These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 16709015

  • 1. Convection-enhanced delivery: targeted toxin treatment of malignant glioma.
    Hall WA, Sherr GT.
    Neurosurg Focus; 2006 Apr 15; 20(4):E10. PubMed ID: 16709015
    [Abstract] [Full Text] [Related]

  • 2. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
    Kunwar S, Chang SM, Prados MD, Berger MS, Sampson JH, Croteau D, Sherman JW, Grahn AY, Shu VS, Dul JL, Husain SR, Joshi BH, Pedain C, Puri RK.
    Neurosurg Focus; 2006 Apr 15; 20(4):E15. PubMed ID: 16709020
    [Abstract] [Full Text] [Related]

  • 3. Convection-enhanced delivery of targeted toxins for malignant glioma.
    Hall WA, Sherr GT.
    Expert Opin Drug Deliv; 2006 May 15; 3(3):371-7. PubMed ID: 16640497
    [Abstract] [Full Text] [Related]

  • 4. Convection-enhanced delivery for treatment of brain tumors.
    Ferguson SD, Foster K, Yamini B.
    Expert Rev Anticancer Ther; 2007 Dec 15; 7(12 Suppl):S79-85. PubMed ID: 18076322
    [Abstract] [Full Text] [Related]

  • 5. Novel therapies for malignant gliomas: a local affair?
    Rainov NG, Söling A, Heidecke V.
    Neurosurg Focus; 2006 Apr 15; 20(4):E9. PubMed ID: 16709040
    [Abstract] [Full Text] [Related]

  • 6. Convection-enhanced delivery in clinical trials.
    Hall WA, Rustamzadeh E, Asher AL.
    Neurosurg Focus; 2003 Feb 15; 14(2):e2. PubMed ID: 15727423
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
    Kondo A, Goldman S, Lulla RR, Mania-Farnell B, Vanin EF, Sredni ST, Rajaram V, Soares MB, Tomita T.
    J Neurosurg Pediatr; 2009 Dec 15; 4(6):592-8. PubMed ID: 19951051
    [Abstract] [Full Text] [Related]

  • 8. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
    Debinski W, Tatter SB.
    Curr Opin Mol Ther; 2010 Dec 15; 12(6):647-53. PubMed ID: 21154156
    [Abstract] [Full Text] [Related]

  • 9. Emerging targeted treatments for malignant glioma.
    Mulholland PJ, Thirlwell C, Brock CS, Newlands ES.
    Expert Opin Emerg Drugs; 2005 Nov 15; 10(4):845-54. PubMed ID: 16262566
    [Abstract] [Full Text] [Related]

  • 10. Future of convection-enhanced delivery in the treatment of brain tumors.
    Bidros DS, Liu JK, Vogelbaum MA.
    Future Oncol; 2010 Jan 15; 6(1):117-25. PubMed ID: 20021213
    [Abstract] [Full Text] [Related]

  • 11. A comprehensive outlook on intracerebral therapy of malignant gliomas.
    Buonerba C, Di Lorenzo G, Marinelli A, Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S, Sampson JH.
    Crit Rev Oncol Hematol; 2011 Oct 15; 80(1):54-68. PubMed ID: 20888252
    [Abstract] [Full Text] [Related]

  • 12. Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas.
    Vandergrift WA, Patel SJ, Nicholas JS, Varma AK.
    Neurosurg Focus; 2006 Apr 15; 20(4):E13. PubMed ID: 16709018
    [Abstract] [Full Text] [Related]

  • 13. Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9.
    Luther N, Cheung NK, Dunkel IJ, Fraser JF, Edgar MA, Gutin PH, Souweidane MM.
    Neurosurgery; 2008 Dec 15; 63(6):1166-74; discussion 1174. PubMed ID: 19057330
    [Abstract] [Full Text] [Related]

  • 14. Clinical studies with targeted toxins in malignant glioma.
    Rainov NG, Söling A.
    Rev Recent Clin Trials; 2006 May 15; 1(2):119-31. PubMed ID: 18473963
    [Abstract] [Full Text] [Related]

  • 15. Intratumoral chemotherapy.
    Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H.
    Neurosurgery; 1995 Dec 15; 37(6):1128-45. PubMed ID: 8584154
    [Abstract] [Full Text] [Related]

  • 16. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
    Nieder C, Grosu AL, Mehta MP, Andratschke N, Molls M.
    Expert Rev Neurother; 2004 Jul 15; 4(4):691-703. PubMed ID: 15853588
    [Abstract] [Full Text] [Related]

  • 17. New treatment strategies for malignant gliomas.
    Sathornsumetee S, Rich JN.
    Expert Rev Anticancer Ther; 2006 Jul 15; 6(7):1087-104. PubMed ID: 16831080
    [Abstract] [Full Text] [Related]

  • 18. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X, Senger DL, Alain T, Oprea A, Parato K, Stojdl D, Lichty B, Power A, Johnston RN, Hamilton M, Parney I, Bell JC, Forsyth PA.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1546-57. PubMed ID: 17077357
    [Abstract] [Full Text] [Related]

  • 19. Convection-enhanced delivery in the treatment of malignant glioma.
    Lopez KA, Waziri AE, Canoll PD, Bruce JN.
    Neurol Res; 2006 Jul 01; 28(5):542-8. PubMed ID: 16808887
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy for malignant gliomas.
    Kreisl TN.
    Semin Radiat Oncol; 2009 Jul 01; 19(3):150-4. PubMed ID: 19464629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.